PMID- 22677547 OWN - NLM STAT- MEDLINE DCOM- 20120830 LR - 20220408 IS - 1549-5477 (Electronic) IS - 0890-9369 (Print) IS - 0890-9369 (Linking) VI - 26 IP - 12 DP - 2012 Jun 15 TI - Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. PG - 1300-5 LID - 10.1101/gad.192856.112 [doi] AB - The Drosophila TEAD ortholog Scalloped is required for Yki-mediated overgrowth but is largely dispensable for normal tissue growth, suggesting that its mammalian counterpart may be exploited for selective inhibition of oncogenic growth driven by YAP hyperactivation. Here we test this hypothesis genetically and pharmacologically. We show that a dominant-negative TEAD molecule does not perturb normal liver growth but potently suppresses hepatomegaly/tumorigenesis resulting from YAP overexpression or Neurofibromin 2 (NF2)/Merlin inactivation. We further identify verteporfin as a small molecule that inhibits TEAD-YAP association and YAP-induced liver overgrowth. These findings provide proof of principle that inhibiting TEAD-YAP interactions is a pharmacologically viable strategy against the YAP oncoprotein. FAU - Liu-Chittenden, Yi AU - Liu-Chittenden Y AD - Howard Hughes Medical Institute, Maryland, USA. FAU - Huang, Bo AU - Huang B FAU - Shim, Joong Sup AU - Shim JS FAU - Chen, Qian AU - Chen Q FAU - Lee, Se-Jin AU - Lee SJ FAU - Anders, Robert A AU - Anders RA FAU - Liu, Jun O AU - Liu JO FAU - Pan, Duojia AU - Pan D LA - eng GR - R01 CA122814/CA/NCI NIH HHS/United States GR - R01EY015708/EY/NEI NIH HHS/United States GR - R01 AR060636/AR/NIAMS NIH HHS/United States GR - R01DK081417/DK/NIDDK NIH HHS/United States GR - R01AR060636/AR/NIAMS NIH HHS/United States GR - R01 EY015708/EY/NEI NIH HHS/United States GR - R01 DK081417/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20120607 PL - United States TA - Genes Dev JT - Genes & development JID - 8711660 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Cell Cycle Proteins) RN - 0 (DNA-Binding Proteins) RN - 0 (Multiprotein Complexes) RN - 0 (Neurofibromin 2) RN - 0 (Phosphoproteins) RN - 0 (Porphyrins) RN - 0 (TEA Domain Transcription Factors) RN - 0 (Tead2 protein, mouse) RN - 0 (Transcription Factors) RN - 0 (YAP-Signaling Proteins) RN - 0 (Yap1 protein, mouse) RN - 0X9PA28K43 (Verteporfin) SB - IM CIN - Genes Dev. 2012 Jun 15;26(12):1263-7. PMID: 22713867 MH - Adaptor Proteins, Signal Transducing/*genetics/metabolism MH - Animals MH - Cell Cycle Proteins MH - Cell Transformation, Neoplastic/metabolism/*pathology MH - DNA-Binding Proteins/*genetics/metabolism MH - Genes, Dominant/genetics MH - HEK293 Cells MH - Hepatomegaly/metabolism/pathology MH - Humans MH - Liver/drug effects/metabolism/pathology MH - Mice MH - Mice, Transgenic MH - Multiprotein Complexes/*metabolism MH - Neurofibromin 2/metabolism MH - Phenotype MH - Phosphoproteins/*genetics/metabolism MH - Porphyrins/*pharmacology MH - Protein Binding/drug effects MH - TEA Domain Transcription Factors MH - Transcription Factors/*genetics/metabolism MH - Verteporfin MH - YAP-Signaling Proteins PMC - PMC3387657 EDAT- 2012/06/09 06:00 MHDA- 2012/08/31 06:00 PMCR- 2012/12/15 CRDT- 2012/06/09 06:00 PHST- 2012/06/09 06:00 [entrez] PHST- 2012/06/09 06:00 [pubmed] PHST- 2012/08/31 06:00 [medline] PHST- 2012/12/15 00:00 [pmc-release] AID - gad.192856.112 [pii] AID - 10.1101/gad.192856.112 [doi] PST - ppublish SO - Genes Dev. 2012 Jun 15;26(12):1300-5. doi: 10.1101/gad.192856.112. Epub 2012 Jun 7.